Lapatinib Tablet

Get a Price/Quote

MOQ : 10 Boxes

Lapatinib Tablet Specification

Brand Name
TYKERB

Packaging Type
TABLET

Recommended For
Clinical

Dosage
AS DIRECTED BY THE PHYSICIAN

Quantity
1*30

Yellow film-coated
Yes

Oral route
Yes

HER2-positive breast cancer
Yes

Cancer therapy
Yes

India origin
Yes

Strip pack
Yes

Prescription only
Yes

Lapatinib Tablet Trade Information

Minimum Order Quantity
10 Boxes

Supply Ability
1000 Boxes Per Month

Delivery Time
7 Days

About Lapatinib Tablet

Introducing TYKERB (Lapatinib Tablet), a cost-effective and popular cancer therapy especially designed for HER2-positive breast cancer. Manufactured in India, this prescription-only tablet represents a matchless combination of efficacy and safety, making it a grandiose choice for both clinicians and patients. The strip pack of yellow, film-coated tablets is gilt-edged in quality, delivering reliability with every dose. Recommended for clinical use, TYKERB stands out as a bargain for exporters, suppliers, and traders seeking proven effectiveness in cancer treatment. Quantity: 1*30 tablets, oral administration, ensures convenience in therapy management.

Lapatinib Tablet Clinical Applications

Lapatinib Tablet (TYKERB) is indicated for oral use under professional supervision. This advanced medication is applied in the management of HER2-positive breast cancer, offering a targeted therapeutic approach. It is predominantly utilized in clinical environments where optimal outcomes are required. Designed for those requiring focused, evidence-based cancer interventions, TYKERB is a preferred option among oncologists and specialists dealing with breast cancer treatment protocols.

Packaging, Shipping, and Delivery Information

Each shipment of Lapatinib Tablet arrives in a secure, strip-packed offering of 1*30 yellow film-coated tablets. We maintain a transparent sample policy and facilitate smooth handover processes to ensure prompt delivery to your FOB port. Our well-coordinated logistics system guarantees products are delivered efficiently and in pristine condition, reflecting our commitment to client satisfaction at each step of the export and transactional journey.

FAQ's of Lapatinib Tablet:

Q: How is Lapatinib Tablet administered for HER2-positive breast cancer?

A: Lapatinib Tablet is taken orally as directed by a physician, as part of treatment for HER2-positive breast cancer. The exact dosage and schedule depend on clinical evaluation and patient response.

Q: What is the recommended packaging type for Lapatinib Tablet?

A: The tablets are packaged in strip packs, with each pack containing 30 yellow film-coated tablets to ensure product integrity and convenience during transport and administration.

Q: Where does TYKERB (Lapatinib Tablet) originate from?

A: TYKERB (Lapatinib Tablet) is manufactured in India, adhering to strict quality and clinical standards for global distribution.

Q: When can I expect the product to be delivered after ordering?

A: Once your order is confirmed and processed, the tablets are handed over to our shipping partners and delivered promptly to the designated FOB port, ensuring timely arrival.

Q: What is the primary area of application for Lapatinib Tablet?

A: Lapatinib Tablet is mainly used in clinical and hospital settings for the management of HER2-positive breast cancer, providing targeted cancer therapy.

Q: What is the benefit of using TYKERB in cancer therapy?

A: TYKERB offers a targeted action for HER2-positive breast cancer, improving patient outcomes and presenting a cost-effective option without compromising quality.

Tell us about your requirement